An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease
Status:
Completed
Trial end date:
1998-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of anti-TNF chimeric
monoclonal antibody (cA2) compared to placebo in the treatment of patients with fistulizing
Crohn's disease.